- Sebetralstat Phase 3 KONFIDENT clinical trial met all endpoints and demonstrated a favorable safety profile as first oral on-demand therapy for hereditary angioedema -
- CEO transition supports.
KalVista Pharmaceuticals, Inc : KalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational Update finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Carter s, Inc. Reports Fourth quarter fiscal 2023 results Net sales $858 million vs. $912 million in Q4 2022 Operating margin 15.9% vs. 12.0% in Q4 2022; adjusted operating margin 15.9% vs. 13.0%.
Financial data from Canadian bank BMO, a major lender to the trucking industry, showed further credit deterioration. The post BMO’s Q1 earnings show more credit deterioration in trucking industry appeared first on FreightWaves.
Copart, Inc. (NASDAQ:CPRT) Q2 2024 Earnings Call Transcript February 22, 2024 Copart, Inc. misses on earnings expectations. Reported EPS is $0.33 EPS, expectations were $0.35. CPRT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, everyone, and welcome to […]